Skip to main content


Section edited by Carlo Agostini

  1. This case is the first report describing rapid, successful treatment of severe atopic dermatitis (AD) and comorbid type-2 inflammatory diseases in the same patient, with dupilumab treatment, with no side-effects.

    Authors: Eustachio Nettis, Lucia Masciopinto, Elisabetta Di Leo, Nicola De Candia, Marcello Albanesi, Danilo Di Bona, Nicola Quaranta and Luigi Macchia

    Citation: Clinical and Molecular Allergy 2021 19:9

    Content type: Case Report

    Published on:

  2. Asthma is a chronic disease characterized by airway hyperresponsiveness, inflammation and mucus production. In Type 2 asthma, two phenotypic components are often co-expressed (eosinophilic and allergic). Eleva...

    Authors: Giorgio Walter Canonica, Francesco Blasi, Nunzio Crimi, Pierluigi Paggiaro, Alberto Papi, Francesca Fanelli, Annalisa Stassaldi and Gianluca Furneri

    Citation: Clinical and Molecular Allergy 2021 19:5

    Content type: Research

    Published on:

  3. Sarcoidosis is a granulomatous disease whose outcome varies from spontaneous remission to chronic refractory disease. Provided that steroids represent the gold standard as a first line treatment, many immune s...

    Authors: Francesco Cinetto, Nicolò Compagno, Riccardo Scarpa, Giacomo Malipiero and Carlo Agostini

    Citation: Clinical and Molecular Allergy 2015 13:19

    Content type: Case Report

    Published on:

The official journal of the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC)

Annual Journal Metrics